OncoSec Medical Incorporated Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

Stockholders' Equity (Details Narrative) - USD ($)						3 Months Ended
Stockholders' Equity (Details Narrative) - USD ($)	Oct. 31, 2018	Oct. 09, 2018	Aug. 31, 2018	Oct. 25, 2017	Jul. 25, 2017	Oct. 31, 2018	Oct. 31, 2017
Number of common stock shares issued related to option exercises	23,411					410,476
Proceeds from stock option exercise						$ 539,719
Warrant to purchase shares of common stock	8,928,905					8,928,905
Gross proceeds from offering						$ 7,446,811	8,058,733
Net proceeds from cash exercise of warrants							9,000
Net proceeds from issuance of public offering						$ 12,671	$ 19,048
Warrant expire term, description						These warrants expire at various dates between May 2019 and May 2025.
Maximum [Member]
Warrant exercise price per share	$ 18.00					$ 18.00
Minimum [Member]
Warrant exercise price per share	$ 1.25					$ 1.25
Alpha Holdings, Inc. [Member]
Gross proceeds from common stock		$ 8,000,000
Number of common stock shares issued		5,333,333
First October 2017 Offering [Member]
Fair value of warrants				$ 2,400,000
Dividend rate				0.00%
Expected term of volatility				5 years 6 months
Volatility rate				75.55%
Risk-free interest rate				2.12%
First October 2017 Offering [Member] \| Placement Agent [Member]
Warrant to purchase shares of common stock				316,256
Warrant exercise price per share				$ 1.68
Warrant expiry date				Oct. 21, 2022
Gross proceeds from offering				$ 7,100,000
Net proceeds from cash exercise of warrants				$ 6,200,000
Percentage of gross proceeds of offering				5.50%
Offering expenses				$ 60,000
Fair value of warrants				$ 200,000
Dividend rate				0.00%
Expected term of volatility				5 years
Volatility rate				73.25%
Risk-free interest rate				2.06%
Second October 2017 Offering [Member] \| Placement Agent [Member]
Warrant to purchase shares of common stock				48,000
Warrant exercise price per share				$ 1.68
Warrant expiry date				Oct. 25, 2022
Gross proceeds from offering				$ 1,100,000
Net proceeds from cash exercise of warrants				$ 1,000,000
Percentage of gross proceeds of offering				5.50%
Offering expenses				$ 15,000
Fair value of warrants				$ 31,000
Dividend rate				0.00%
Expected term of volatility				5 years
Volatility rate				73.22%
Risk-free interest rate				2.06%
Second October 2017 Offering [Member]
Fair value of warrants				$ 400,000
Dividend rate				0.00%
Expected term of volatility				5 years 6 months
Volatility rate				75.51%
Risk-free interest rate				2.12%
Accredited Investors [Member] \| First October 2017 Offering [Member]
Number of common stock shares sold under offering				5,270,934
Purchase price per share				$ 1.34375
Warrant exercise price per share				$ 1.25
Warrant expiry date				Apr. 25, 2022
Warrant exercisable date				Oct. 25, 2017
Accredited Investors [Member] \| First October 2017 Offering [Member] \| Maximum [Member]
Warrant to purchase shares of common stock				3,953,200
Accredited Investors [Member] \| Second October 2017 Offering [Member]
Number of common stock shares sold under offering				800,000
Purchase price per share				$ 1.34375
Warrant exercise price per share				$ 1.25
Warrant expiry date				Apr. 27, 2022
Warrant exercisable date				Apr. 27, 2018
Accredited Investors [Member] \| Second October 2017 Offering [Member] \| Maximum [Member]
Warrant to purchase shares of common stock				600,000
Stock Purchase Agreement [Member] \| Alpha Holdings, Inc. [Member]
Purchase price per share			$ 1.50
Stock Purchase Agreement [Member] \| Alpha Holdings, Inc. [Member] \| Maximum [Member]
Number of common stock shares sold, value			$ 15,000,000
Equity Distribution Agreement [Member] \| Oppenheimer & Co. Inc [Member]
Number of common stock shares sold under offering							897,311
Net proceeds from issuance of public offering					$ 1,100,000
Equity Distribution Agreement [Member] \| Oppenheimer & Co. Inc [Member] \| Maximum [Member]
Gross proceeds from offering					$ 8,400,000